CLC Number: 

  • R575.6+2
[1] Manes G, Paspatis G, Aabakken L, et al. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy(ESGE)guideline[J]. Endoscopy, 2019, 51(5): 472-491.
[2] Cianci P, Restini E. Management of cholelithiasis with choledocholithiasis: Endoscopic and surgical approaches[J]. World J Gastroenterol, 2021, 27(28): 4536-4554.
[3] Troncone E, Mossa M, De Vico P, Monteleone G, Del Vecchio Blanco G. Difficult biliary stones: a comprehensive review of new and old lithotripsy techniques[J]. Medicina(Kaunas), 2022, 58(1): 120.
[4] Horiuchi A, Nakayama Y, Kajiyama M, et al. Biliary stenting in the management of large or multiple common bile duct stones[J]. Gastrointest Endosc, 2010, 71(7): 1200-1203.
[5] Williams E, Beckingham I, El Sayed G, et al. Updated guideline on the management of common bile duct stones(CBDS)[J]. Gut, 2017, 66(5):765-782.
[6] ASGE Standards of Practice Committee, Buxbaum JL, Abbas Fehmi SM, et al. ASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasis[J]. Gastrointest Endosc, 2019, 89(6): 1075-1105.
[7] Choi JH, Lee TY, Cheon YK. Effect of stent placement on stone recurrence and post-procedural cholangitis after endoscopic removal of common bile duct stones[J]. Korean J Intern Med, 2021, 36(1): 27-34.
[8] Yang J, Peng JY, Chen W. Endoscopic biliary stenting for irretrievable common bile duct stones: Indications, advantages, disadvantages, and follow-up results[J]. Surgeon, 2012, 10(4): 211-217.
[9] Kaneko J, Kawata K, Watanabe S, et al. Clinical characteristics and risk factors for stent-stone complex formation following biliary plastic stent placement in patients with common bile duct stones[J]. J Hepatobiliary Pancreat Sci, 2018, 25(10): 448-454.
[10] Chen X, Yan XR, Zhang LP. Ursodeoxycholic acid after common bile duct stones removal for prevention of recurrence: A systematic review and meta-analysis of randomized controlled trials[J]. Medicine(Baltimore), 2018, 97(45): e13086. doi: 10.1097/MD.0000000000013086.
[11] Hormati A, Ghadir MR, Sarkeshikian SS, et al. Adding ursodeoxycholic acid to the endoscopic treatment and common bile duct stenting for large and multiple biliary stones: Will it improve the outcomes?[J]. BMC Gastroenterol, 2020, 20(1): 374.
[12] Li Q, Tao L, Wu X, Mou L, et al. Bile duct stone formation around a Prolene suture after cholangioenterostomy[J]. Pak J Med Sci, 2016, 32(1): 263-266.
[13] Ban JL, Hirose FM, Benfield JR. Foreign bodies of the biliary tract: report of two patients and a review of the literature[J]. Ann Surg, 1972, 176(1): 102-107.
[14] Beardsley C, Lim J, Gananadha S. Nonabsorbable suture material in the biliary tract[J]. J Gastrointest Surg, 2012, 16(11): 2182-2183.
[15] Jeans P, Hall P, Liu YF, et al. Maxon is an optimal suture for bile duct anastomoses in pigs[J]. HPB Surg, 1993, 7(2): 111-124.
[16] McNicoll CF, Pastorino A, Farooq U, et al. Choledocholithiasis[M]. Treasure Island(FL): StatPearls Publishing,July 10, 2023.
[17] Lin CK, Huang WC. Prolonged cholestasis following endoscopic retrograde cholangiopancreatography, a rare complication of contrast agent induced liver injury: a case report and literature review[J]. Medicine(Baltimore), 2020, 99(3): e18855. doi: 10.1097/MD.0000000000018855.
No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!